Unipharma Group
Distributor, Agent, Licensee for Pathelen Hybrid (Wound Powder) Pathelen® Woundpowder (Hybrid) – Pathelen is a new microporous silica powder, that adsorbs wound exudate, reducing the healing time of chronic wounds and offers a cost-effective alternative to the current treatment options for wounds. Pathelen® Hybrid (European Class 1 Certified Medical Device), a pioneering, side effect free treatment for open wound infections like MRSA, MDR, ESBL, and antibiotic-resistant bacteria (Superbugs), advancing existing capabilities of wound-care in public, private and military hospitals.
7-day free trial · no credit card
Verified contacts
3
available on Kipplo
LinkedIn employees
15
11 to 50 range
Open roles
—
no listings
Distinct roles
3
indexed titles
Tech stack
0
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 3 verified contacts at Unipharma Group
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
3 contacts with verified email or phone · masked until revealed.
No verified contacts on record for this company yet.
Top roles at Unipharma Group
3 distinct titles indexed · top 3 shown.
- 1chief communication and development officer (cco & cdo)
- 1chief executive officer (nigeria)
- 1regional sales manager
Sign up to unlock all 3 contacts at Unipharma Group
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 3 verified contacts at Unipharma Group
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.